Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Oncotarget ; 8(33): 55332-55352, 2017 Aug 15.
Article in English | MEDLINE | ID: mdl-28903423

ABSTRACT

Tumor cells undergo a critical remodeling of intracellular Ca2+ homeostasis that contribute to important cancer hallmarks. Store-operated Ca2+ entry (SOCE), a Ca2+ entry pathway modulated by mitochondria, is dramatically enhanced in colon cancer cells. In addition, most cancer cells display the Warburg effect, a metabolic switch from mitochondrial metabolism to glycolysis that provides survival advantages. Accordingly, we investigated mitochondria control of store-operated currents (SOCs) in two cell lines previously selected for representing human normal colonic cells and colon cancer cells. We found that, in normal cells, mitochondria are important for SOCs activity but they are unable to prevent current inactivation. In contrast, in colon cancer cells, mitochondria are dispensable for SOCs activation but are able to prevent the slow, Ca2+-dependent inactivation of SOCs. This effect is associated to increased ability of tumor cell mitochondria to take up Ca2+ due to increased mitochondrial potential (ΔΨ) linked to the Warburg effect. Consistently with this view, selected non-steroidal anti-inflammatory drugs (NSAIDs) depolarize mitochondria, inhibit mitochondrial Ca2+ uptake and promote SOC inactivation, leading to inhibition of both SOCE and cancer cell proliferation. Thus, mitochondria sustain store-operated currents in colon cancer cells but not in normal colonic cells and this effect is counteracted by selected NSAIDs providing a mechanism for cancer chemoprevention.

2.
J Biol Chem ; 286(18): 16186-96, 2011 May 06.
Article in English | MEDLINE | ID: mdl-21402693

ABSTRACT

Abnormal vascular smooth muscle cell (VSMC) proliferation contributes to occlusive and proliferative disorders of the vessel wall. Salicylate and other nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit VSMC proliferation by an unknown mechanism unrelated to anti-inflammatory activity. In search for this mechanism, we have studied the effects of salicylate and other NSAIDs on subcellular Ca(2+) homeostasis and Ca(2+)-dependent cell proliferation in rat aortic A10 cells, a model of neointimal VSMCs. We found that A10 cells displayed both store-operated Ca(2+) entry (SOCE) and voltage-operated Ca(2+) entry (VOCE), the former being more important quantitatively than the latter. Inhibition of SOCE by specific Ca(2+) released-activated Ca(2+) (CRAC/Orai) channels antagonists prevented A10 cell proliferation. Salicylate and other NSAIDs, including ibuprofen, indomethacin, and sulindac, inhibited SOCE and thereby Ca(2+)-dependent, A10 cell proliferation. SOCE, but not VOCE, induced mitochondrial Ca(2+) uptake in A10 cells, and mitochondrial depolarization prevented SOCE, thus suggesting that mitochondrial Ca(2+) uptake controls SOCE (but not VOCE) in A10 cells. NSAIDs depolarized mitochondria and prevented mitochondrial Ca(2+) uptake, suggesting that they favor the Ca(2+)-dependent inactivation of CRAC/Orai channels. NSAIDs also inhibited SOCE in rat basophilic leukemia cells where mitochondrial control of CRAC/Orai is well established. NSAIDs accelerate slow inactivation of CRAC currents in rat basophilic leukemia cells under weak Ca(2+) buffering conditions but not in strong Ca(2+) buffer, thus excluding that NSAIDs inhibit SOCE directly. Taken together, our results indicate that NSAIDs inhibit VSMC proliferation by facilitating the Ca(2+)-dependent inactivation of CRAC/Orai channels which normally is prevented by mitochondria clearing of entering Ca(2+).


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Calcium Channels/metabolism , Calcium/metabolism , Cell Proliferation/drug effects , Ion Channel Gating/drug effects , Mitochondria, Muscle/metabolism , Myocytes, Smooth Muscle/metabolism , Animals , Cell Line, Tumor , Membrane Potential, Mitochondrial/drug effects , Mitochondria, Muscle/pathology , Myocytes, Smooth Muscle/pathology , Rats , Vascular Diseases/metabolism , Vascular Diseases/pathology
3.
Traffic ; 11(9): 1221-33, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20573066

ABSTRACT

Rapid control of protein degradation is usually achieved through the ubiquitin-proteasome pathway. We recently found that the short-lived GTPase RhoB is degraded in lysosomes. Moreover, the fusion of the RhoB C-terminal sequence CINCCKVL, containing the isoprenylation and palmitoylation sites, to other proteins directs their sorting into multivesicular bodies (MVBs) and rapid lysosomal degradation. Here, we show that this process is highly specific for RhoB. Alteration of late endosome lipid dynamics produced the accumulation of RhoB, but not of other endosomal GTPases, including Rab5, Rab7, Rab9 or Rab11, into enlarged MVB. Other isoprenylated and bipalmitoylated GTPases, such as H-Ras, Rap2A, Rap2B and TC10, were not accumulated into MVB and were stable. Remarkably, although TC10, which is highly homologous to RhoB, was stable, a sequence derived from its C-terminus (CINCCLIT) elicited MVB sorting and degradation of a green fluorescent protein (GFP)-chimeric protein. This led us to identify a cluster of basic amino acids (KKH) in the TC10 hypervariable region, constituting a secondary signal potentially involved in electrostatic interactions with membrane lipids. Mutation of this cluster allowed TC10 MVB sorting and degradation, whereas inserting it into RhoB hypervariable region rescued this protein from its lysosomal degradation pathway. These findings define a highly specific structural module for entering the MVB pathway and rapid lysosomal degradation.


Subject(s)
Endosomal Sorting Complexes Required for Transport , Endosomes/enzymology , GTP Phosphohydrolases/chemistry , GTP Phosphohydrolases/metabolism , Lysosomes/metabolism , rhoB GTP-Binding Protein , Amino Acid Sequence , Animals , Endosomal Sorting Complexes Required for Transport/chemistry , Endosomal Sorting Complexes Required for Transport/metabolism , Humans , Molecular Sequence Data , rhoB GTP-Binding Protein/metabolism
4.
J Cell Biol ; 183(4): 697-710, 2008 Nov 17.
Article in English | MEDLINE | ID: mdl-19015318

ABSTRACT

The active vitamin D metabolite 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) inhibits proliferation and promotes differentiation of colon cancer cells through the activation of vitamin D receptor (VDR), a transcription factor of the nuclear receptor superfamily. Additionally, 1,25(OH)(2)D(3) has several nongenomic effects of uncertain relevance. We show that 1,25(OH)(2)D(3) induces a transcription-independent Ca(2+) influx and activation of RhoA-Rho-associated coiled kinase (ROCK). This requires VDR and is followed by activation of the p38 mitogen-activated protein kinase (p38MAPK) and mitogen- and stress-activated kinase 1 (MSK1). As shown by the use of chemical inhibitors, dominant-negative mutants and small interfering RNA, RhoA-ROCK, and p38MAPK-MSK1 activation is necessary for the induction of CDH1/E-cadherin, CYP24, and other genes and of an adhesive phenotype by 1,25(OH)(2)D(3). RhoA-ROCK and MSK1 are also required for the inhibition of Wnt-beta-catenin pathway and cell proliferation. Thus, the action of 1,25(OH)(2)D(3) on colon carcinoma cells depends on the dual action of VDR as a transcription factor and a nongenomic activator of RhoA-ROCK and p38MAPK-MSK1.


Subject(s)
Calcitriol/pharmacology , Colonic Neoplasms/enzymology , Ribosomal Protein S6 Kinases, 90-kDa/metabolism , Vitamins/metabolism , Wnt Proteins/metabolism , p38 Mitogen-Activated Protein Kinases/metabolism , rho GTP-Binding Proteins/metabolism , rho-Associated Kinases/metabolism , rhoA GTP-Binding Protein/metabolism , Animals , Antigens, CD , Caco-2 Cells , Cadherins/genetics , Cadherins/metabolism , Calcitriol/metabolism , Calcium/metabolism , Cdh1 Proteins , Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Cell Proliferation/drug effects , Colonic Neoplasms/genetics , Enzyme Activation/drug effects , Humans , Mice , NIH 3T3 Cells , Receptors, Calcitriol/genetics , Receptors, Calcitriol/metabolism , Ribosomal Protein S6 Kinases, 90-kDa/genetics , Steroid Hydroxylases/genetics , Steroid Hydroxylases/metabolism , Transcription, Genetic/drug effects , Vitamin D3 24-Hydroxylase , Vitamins/pharmacology , Wnt Proteins/genetics , beta Catenin/genetics , beta Catenin/metabolism , p38 Mitogen-Activated Protein Kinases/genetics , rho GTP-Binding Proteins/genetics , rho-Associated Kinases/genetics , rhoA GTP-Binding Protein/genetics
5.
PLoS One ; 3(7): e2718, 2008 Jul 23.
Article in English | MEDLINE | ID: mdl-18648507

ABSTRACT

Dysregulation of intracellular Ca(2+) homeostasis may underlie amyloid beta peptide (Abeta) toxicity in Alzheimer's Disease (AD) but the mechanism is unknown. In search for this mechanism we found that Abeta(1-42) oligomers, the assembly state correlating best with cognitive decline in AD, but not Abeta fibrils, induce a massive entry of Ca(2+) in neurons and promote mitochondrial Ca(2+) overload as shown by bioluminescence imaging of targeted aequorin in individual neurons. Abeta oligomers induce also mitochondrial permeability transition, cytochrome c release, apoptosis and cell death. Mitochondrial depolarization prevents mitochondrial Ca(2+) overload, cytochrome c release and cell death. In addition, we found that a series of non-steroidal anti-inflammatory drugs (NSAIDs) including salicylate, sulindac sulfide, indomethacin, ibuprofen and R-flurbiprofen depolarize mitochondria and inhibit mitochondrial Ca(2+) overload, cytochrome c release and cell death induced by Abeta oligomers. Our results indicate that i) mitochondrial Ca(2+) overload underlies the neurotoxicity induced by Abeta oligomers and ii) inhibition of mitochondrial Ca(2+) overload provides a novel mechanism of neuroprotection by NSAIDs against Abeta oligomers and AD.


Subject(s)
Amyloid beta-Peptides/chemistry , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Calcium/chemistry , Mitochondria/metabolism , Neuroprotective Agents/pharmacology , Animals , Apoptosis , Calcium/metabolism , Cerebellum/metabolism , Cytochromes c/metabolism , Membrane Potentials , Models, Biological , Neurons/metabolism , Rats , Rats, Wistar , Reactive Oxygen Species
6.
Cell Calcium ; 44(3): 259-69, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18241916

ABSTRACT

Store-operated Ca2+ entry (SOCE), a Ca2+ influx pathway involved in cell proliferation, depends on mitochondrial Ca2+ uptake, a Ca2+ influx that is driven by the mitochondrial potential (DeltaPsi). Whereas much attention has been paid to the Ca2+-dependence of mitochondrial Ca2+ uptake, its dependence on DeltaPsi remains largely in qualitative terms. We have studied the dose-dependent effects of a mild mitochondrial uncoupler, salicylate, on DeltaPsi, mitochondrial Ca2+ concentration ([Ca2+]mit), SOCE and cell proliferation by fluorescence microscopy and photon counting of cells expressing a low-affinity aequorin targeted to mitochondria. These data and a novel algorithm to convert fluorescence values of tetramethylrhodamine (TMR) probes into millivolts provide the opportunity of quantifying the relationship among the above parameters. We found that a small mitochondrial depolarisation is sufficient to inhibit largely mitochondrial Ca2+ uptake, leading to SOCE inactivation and prevention of cell proliferation. Conversely, mitochondrial hyperpolarisation increased the activity of the Ca2+-dependent transcription factor NFAT and promoted cell proliferation. Thus, small changes in DeltaPsi influence largely Ca2+ uptake by mitochondria, cytosolic Ca2+ signals and the downstream signalling pathway to cell proliferation.


Subject(s)
Calcium/metabolism , Cell Proliferation , Membrane Potential, Mitochondrial/physiology , Mitochondria/metabolism , Aequorin/metabolism , Aniline Compounds/metabolism , Calcium Signaling , Humans , Jurkat Cells , Microscopy, Fluorescence , Oxazoles/metabolism
7.
J Physiol ; 571(Pt 1): 57-73, 2006 Feb 15.
Article in English | MEDLINE | ID: mdl-16339178

ABSTRACT

Store-operated Ca2+ entry (SOCE) is a ubiquitous Ca2+ influx pathway involved in control of multiple cellular and physiological processes including cell proliferation. Recent evidence has shown that SOCE depends critically on mitochondrial sinking of entering Ca2+ to avoid Ca2+-dependent inactivation. Thus, a role of mitochondria in control of cell proliferation could be anticipated. We show here that activation of SOCE induces cytosolic high [Ca2+] domains that are large enough to be sensed and avidly taken up by a pool of nearby mitochondria. Prevention of mitochondrial clearance of the entering Ca2+ inhibited both SOCE and cell proliferation in several cell types including Jurkat and human colon cancer cells. In addition, we find that therapeutic concentrations of salicylate, the major metabolite of aspirin, depolarize partially mitochondria and inhibit mitochondrial Ca2+ uptake, as revealed by mitochondrial Ca2+ measurements with targeted aequorins. This salicylate-induced inhibition of mitochondrial Ca2+ sinking prevented SOCE and impaired cell growth of Jurkat and human colon cancer cells. Finally, direct blockade of SOCE by the pyrazole derivative BTP-2 was sufficient to arrest cell growth. Taken together, our results reveal that cell proliferation depends critically on mitochondrial Ca2+ uptake and suggest that inhibition of tumour cell proliferation by salicylate may be due to interference with mitochondrial Ca2+ uptake, which is essential for sustaining SOCE. This novel mechanism may contribute to explaining the reported anti-proliferative and anti-tumoral actions of aspirin and dietary salicylates.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Calcium/metabolism , Cell Proliferation/drug effects , Mitochondria/metabolism , Salicylates/pharmacology , Anilides/pharmacology , Cell Survival/drug effects , Cytosol/chemistry , HT29 Cells , Humans , Jurkat Cells , Membrane Potentials/drug effects , Mitochondria/drug effects , Mitochondrial Membranes/drug effects , Mitochondrial Membranes/physiology , Thiadiazoles/pharmacology , Transcription, Genetic/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...